OS Therapies (OSTX) Stock: Buy, Sell, or Hold?
$0.75
-0.01 (-0.68%)
▼
5d:
-25.5%
30d:
-47.16%
90d:
-49.32%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (57%)
Quality Score
41/100
Position
OVERSOLD
30-Day Fair Range
$0.99 – $1.48
Position: OVERSOLD
Forward P/E & Valuation
2.1x
CHEAP
vs 4.3x historical avg
Wall Street Target
$8.25
+1007.4% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.58 / $1.30
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: OSTX is down 25.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When OSTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$2.11
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$1.31
43.1% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 4.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: OSTX is currently trading at $0.74, which is considered oversold relative to its 30-day fair value range of $0.99 to $1.48. From a valuation perspective, the stock is trading at a discount (Forward PE: 2.1) compared to its historical average (4.3). Remarkably, the market is currently pricing in an annual earnings decline of 20.9% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, OSTX is in a downtrend. Immediate support is located at $0.58, while resistance sits at $1.30.
Market Sentiment: OSTX scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $8.25 (+1007.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, OSTX is in a downtrend. Immediate support is located at $0.58, while resistance sits at $1.30.
Market Sentiment: OSTX scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $8.25 (+1007.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.99 -
$1.48
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
Trading Range & Key Levels
30-Day Trading Range
$0.99 -
$1.48
Current vs Trading Range
OVERSOLD
Support Level
$0.58
Resistance Level
$1.30
Current Trend
Downtrend
Technical data as of
Nov 13, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1007.4% below Wall St target ($8.25)
- WARNING: Composite score 41/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
2.13
Wall Street Target
$8.25
(+1007.4%)
Valuation Discount vs History
-20.9% cheaper
PE vs Historical
2.1 vs 4.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-20.9%
(market-implied from PE analysis)
1-Year Target
$0.67
(-10%)
2-Year Target
$0.60
(-19%)
3-Year Target
$0.54
(-27%)
3-Yr Target (if PE normalizes)
(PE: 2→4)
$1.10
(+47%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 2.1 to 4.3
Stabilization Target:
$1.50
(+102.0%)
PE Expansion Potential:
+102.0%
Share OSTX Analysis
Share this live OSTX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (OSTX)
Bullish
4 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
3 msgs
24h retail stream
Last Tracked
Nov 13, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits messages indicate a bullish sentiment towards $OSTX, with traders expressing confidence in the stock's direction and anticipating purchases. No significant news articles were found.
Key Retail Themes:
traders' confidence in the stock's direction
anticipation of purchases
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 5:34 PM ET
Data refreshes hourly during market hours. Next update: 6:34 PM
Data refreshes hourly during market hours. Next update: 6:34 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OSTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$107 | 69 BUY |
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$194 | 41 HOLD |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
19 analysts |
$689 | 48 HOLD |
|
IMNM
Immunome Inc |
STRONG BUY
17 analysts |
$35 | 47 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$86 | 46 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive OSTX Research Pages
